University funds have a unique opportunity to bridge the gap to commercialization.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Kneller, R. Nat. Rev. Drug Discov. 9, 867–882 (2010)
National Venture Capital Association. Venture capital firms raise $5.6B in fourth quarter 2011 as industry continues to consolidate (Thomson Reuters news release, 9 January 2012).
National Venture Capital Association. Venture capital investments experience double-digit increases in dollars and deal volume in Q2 2012: internet-specific and early stage investing jumps; life sciences investing falls (Thomson Reuters news release, 20 July 2012).
Booth, B.L. Nat. Biotechnol. 27, 705–709 (2009).
Booth, B.L. & Salehizadeh, B. Nat. Biotechnol. 29, 579–583 (2011).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Christini, A. Why universities should step up in venture investing. Nat Biotechnol 30, 933–936 (2012). https://doi.org/10.1038/nbt.2390
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt.2390
This article is cited by
-
Raising financing through strategic timing
Nature Nanotechnology (2017)